Understanding the IgE antibody response in alpha-gal syndrome
Official title: Molecular details of the IgE antibody response to galactose-alpha-1,3-galactose in alpha-gal syndrome
Funded at Vanderbilt University Medical Center · NIH-11106940 · Data updated 2026-11-12
This study is looking at how certain antibodies in people with alpha-gal syndrome react to a specific allergen found in red meat, to help improve how we diagnose and treat this allergy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project start | March 1, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $753,304 |
| NIH project number | 1R01AI189950-01 |
| Project ID | NIH-11106940 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with alpha-gal syndrome who experience allergic reactions to red meat.
✕Less likely to help
Patients who do not have alpha-gal syndrome or are not allergic to red meat may not benefit from this research.
What this research studies
This research investigates how the IgE antibodies respond to the allergen galactose-alpha-1,3-galactose in individuals with alpha-gal syndrome, a condition that can cause severe allergic reactions to red meat. By isolating specific IgE antibodies from allergic patients, the study aims to understand the molecular interactions between these antibodies and the allergen. This approach allows for a more precise examination of the immune response, which has been limited in previous studies that used mixed serum samples. The findings could lead to better diagnostic and therapeutic strategies for managing this allergy.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and management strategies for patients suffering from alpha-gal syndrome.
How similar studies have gone: While research on IgE responses has been conducted, this specific approach using naturally occurring human IgE monoclonal antibodies in alpha-gal syndrome is novel and has not been extensively tested.
Where this research is happening
-
Vanderbilt University Medical Center
Nashville, United States Active
Researchers
- Principal investigator: Smith, Scott Alan — Vanderbilt University Medical Center
- Study coordinator: Smith, Scott Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.